Dr Hadeel Issa Naqib, MD - Medicare Pediatrics in Baltimore, MD

Dr Hadeel Issa Naqib, MD is a medicare enrolled "Pediatrics" physician in Baltimore, Maryland. Her current practice location is 1232 Race Rd, Suite 201, Baltimore, Maryland. You can reach out to her office (for appointments etc.) via phone at (410) 687-6434.

Dr Hadeel Issa Naqib is licensed to practice in Maryland (license number D0041989) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1043282783.

Contact Information

Dr Hadeel Issa Naqib, MD
1232 Race Rd, Suite 201,
Baltimore, MD 21237-2351
(410) 687-6434
(410) 687-9855



Physician's Profile

Full NameDr Hadeel Issa Naqib
GenderFemale
SpecialityPediatrics
Location1232 Race Rd, Baltimore, Maryland
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1043282783
  • Provider Enumeration Date: 02/06/2006
  • Last Update Date: 06/18/2012
  Medicare PECOS Information:
  • PECOS PAC ID: 9830351410
  • Enrollment ID: I20201023000094

Medical Identifiers

Medical identifiers for Dr Hadeel Issa Naqib such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1043282783NPI-NPPES
760851900MedicaidMD

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208000000XPediatrics D0041989 (Maryland)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Hadeel Issa Naqib allows following entities to bill medicare on her behalf.
Entity NameUpmc Wellsboro
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1427501766
PECOS PAC ID: 5294710414
Enrollment ID: O20160913001277

News Archive

Confocal microscope designed specifically for scientists launched by Caliber ID

Caliber Imaging & Diagnostics, Inc. (Caliber I.D.), an Andover, MA-based medical technologies company with more than 20 years of experience in the design and development of innovative imaging solutions for the examination of tissue at the cellular level, has introduced its first confocal microscope exclusively for the research scientist, the RS-G4.

Relypsa announces positive results from Phase 2 clinical trial of RLY5016

Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.

How to avoid shoulder injury related to vaccine administration

A study by researchers at the University of Waterloo reiterates the need for health care professionals, including pharmacists, to take certain precautions to minimize the risk of their patients suffering shoulder injury related to vaccine administration

Researchers identify new therapeutic approach for stroke treatment

For the first time, research led by Youming Lu, PhD, MD, Professor of Neurology and Neuroscience at LSU Health Sciences Center New Orleans School of Medicine, has identified a novel mechanism that may trigger brain damage during stroke and identified a therapeutic approach to block it.

John Theurer to host 9th annual neuro-oncology symposium on May 17

John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, will host its Ninth Annual Neuro-Oncology Symposium on Friday, May 17th from 8:00am-1:00pm. Experts from MD Anderson, Memorial Sloan Kettering Cancer Center, Penn State Milton S. Hershey Medical Center, and the Cleveland Clinic will present advances in multidisciplinary care for cancers of the central nervous system.

Read more Medical News

› Verified 2 days ago

Entity NameUpmc Wellsboro
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1275090433
PECOS PAC ID: 5294710414
Enrollment ID: O20190709001759

News Archive

Confocal microscope designed specifically for scientists launched by Caliber ID

Caliber Imaging & Diagnostics, Inc. (Caliber I.D.), an Andover, MA-based medical technologies company with more than 20 years of experience in the design and development of innovative imaging solutions for the examination of tissue at the cellular level, has introduced its first confocal microscope exclusively for the research scientist, the RS-G4.

Relypsa announces positive results from Phase 2 clinical trial of RLY5016

Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.

How to avoid shoulder injury related to vaccine administration

A study by researchers at the University of Waterloo reiterates the need for health care professionals, including pharmacists, to take certain precautions to minimize the risk of their patients suffering shoulder injury related to vaccine administration

Researchers identify new therapeutic approach for stroke treatment

For the first time, research led by Youming Lu, PhD, MD, Professor of Neurology and Neuroscience at LSU Health Sciences Center New Orleans School of Medicine, has identified a novel mechanism that may trigger brain damage during stroke and identified a therapeutic approach to block it.

John Theurer to host 9th annual neuro-oncology symposium on May 17

John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, will host its Ninth Annual Neuro-Oncology Symposium on Friday, May 17th from 8:00am-1:00pm. Experts from MD Anderson, Memorial Sloan Kettering Cancer Center, Penn State Milton S. Hershey Medical Center, and the Cleveland Clinic will present advances in multidisciplinary care for cancers of the central nervous system.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Hadeel Issa Naqib is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Hadeel Issa Naqib, MD
1232 Race Rd, Suite 201,
Baltimore, MD 21237-2351

Ph: (410) 687-6434
Dr Hadeel Issa Naqib, MD
1232 Race Rd, Suite 201,
Baltimore, MD 21237-2351

Ph: (410) 687-6434

News Archive

Confocal microscope designed specifically for scientists launched by Caliber ID

Caliber Imaging & Diagnostics, Inc. (Caliber I.D.), an Andover, MA-based medical technologies company with more than 20 years of experience in the design and development of innovative imaging solutions for the examination of tissue at the cellular level, has introduced its first confocal microscope exclusively for the research scientist, the RS-G4.

Relypsa announces positive results from Phase 2 clinical trial of RLY5016

Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.

How to avoid shoulder injury related to vaccine administration

A study by researchers at the University of Waterloo reiterates the need for health care professionals, including pharmacists, to take certain precautions to minimize the risk of their patients suffering shoulder injury related to vaccine administration

Researchers identify new therapeutic approach for stroke treatment

For the first time, research led by Youming Lu, PhD, MD, Professor of Neurology and Neuroscience at LSU Health Sciences Center New Orleans School of Medicine, has identified a novel mechanism that may trigger brain damage during stroke and identified a therapeutic approach to block it.

John Theurer to host 9th annual neuro-oncology symposium on May 17

John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, will host its Ninth Annual Neuro-Oncology Symposium on Friday, May 17th from 8:00am-1:00pm. Experts from MD Anderson, Memorial Sloan Kettering Cancer Center, Penn State Milton S. Hershey Medical Center, and the Cleveland Clinic will present advances in multidisciplinary care for cancers of the central nervous system.

Read more News

› Verified 2 days ago


Pediatrics Doctors in Baltimore, MD

Hilary Tamara Wolf, MD
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 22 S Greene St, Baltimore, MD 21201
Phone: 410-328-7373    Fax: 410-328-7305
Dr. Carmel Bogle, M.D.
Pediatrics
Medicare: Accepting Medicare Assignments
Practice Location: 1800 Orleans St, Baltimore, MD 21287
Phone: 443-287-0526    Fax: 410-955-0897
Anna Eunjoo Choe,
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 615 N Wolfe St Rm Wb602, Baltimore, MD 21205
Phone: 410-955-3362    Fax: 410-614-1582
Dr. Melissa Lauren Shapiro, M.D.
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 2411 W Belvedere Ave Ste 407, Baltimore, MD 21215
Phone: 410-601-8663    
Dr. Alexander James Jaksic, MD
Pediatrics
Medicare: Not Enrolled in Medicare
Practice Location: 600 N Wolfe St, Baltimore, MD 21287
Phone: 781-223-0948    
Adam J Spanier, M.D.
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 300 Armory Pl, Baltimore, MD 21201
Phone: 410-225-8780    Fax: 410-225-8766
Milagritos D Tapia, MD
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 22 S Greene St, Baltimore, MD 21201
Phone: 410-328-6749    Fax: 410-328-6136

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.